Through
11/26
A round-up of Penn mentions in local, national, and international media.
Penn In the News
Benjamin Keys of the Wharton School says the changing landscape in insurance markets is a recognition that risks have increased in recent years.
Penn In the News
Kent Smetters of the Wharton School says that interest payments will likely overcome the amount the U.S. spends on national defense within a couple years.
Penn In the News
Jeremy Siegel of the Wharton School believes that the Federal Reserve will not hike rates again on Nov. 1st because of the bond market.
Penn In the News
In an Op-Ed, Adam Grant of the Wharton School explains why “brainwriting” is better than brainstorming for unearthing the hidden potential in teams.
Penn In the News
A study by Christoph Thaiss and Maayan Levy of the Perelman School of Medicine and colleagues finds that long COVID’s neurological symptoms, like brain fog, memory loss, and fatigue, may stem from serotonin reduction.
Penn In the News
Kartik Hosanagar of the Wharton School says that the large data sets and deep technical expertise required to build AI products mean that students have much to learn on-campus before striking out on their own.
Penn In the News
A study by Christoph Thaiss and Maayan Levy of the Perelman School of Medicine and colleagues suggests that serotonin could be a target for long COVID treatment.
Penn In the News
Jalpa Doshi of the Perelman School of Medicine says that as market competition increases for weight-loss drugs, prices will decrease accordingly.
Penn In the News
A study by Christoph Thaiss and Maayan Levy of the Perelman School of Medicine and colleagues suggests that several current hypotheses for the pathophysiology of long COVID are linked by a single pathway that is connected by serotonin reduction.
Penn In the News
Jonah Berger of the Wharton School says that translating the climate crisis into an effective marketing campaign means focusing not on the abstract importance of the issue but on the concrete needs of the audience.